| Issue Date | Title | Author(s) |
| 2019-01-01 | Increase in DNA damage by MYCN knockdown through regulating nucleosome organization and chromatin state in neuroblastoma | Hu, X; Zheng, W; Zhu, Q; Gu, L; Du, Y; Han, Z; Zhang, X; Carter, DR; Cheung, BB; Qiu, A; Jiang, C |
| 2020-10 | Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma. | Tee, AE; Ciampa, OC; Wong, M; Fletcher, JI; Kamili, A; Chen, J; Ho, N; Sun, Y; Carter, DR; Cheung, BB; Marshall, GM; Liu, PY; Liu, T |
| 2019-11-05 | The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35. | Liu, PY; Tee, AE; Milazzo, G; Hannan, KM; Maag, J; Mondal, S; Atmadibrata, B; Bartonicek, N; Peng, H; Ho, N; Mayoh, C; Ciaccio, R; Sun, Y; Henderson, MJ; Gao, J; Everaert, C; Hulme, AJ; Wong, M; Lan, Q; Cheung, BB; Shi, L; Wang, JY; Simon, T; Fischer, M; Zhang, XD; Marshall, GM; Norris, MD; Haber, M; Vandesompele, J; Li, J; Mestdagh, P; Hannan, RD; Dinger, ME; Perini, G; Liu, T |
| 2019-09-04 | Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis | Sutton, SK; Cheung, BB; Massudi, H; Tan, O; Koach, J; Mayoh, C; Carter, DR; Marshall, GM |
| 2018-06-15 | Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN | Ooi, CY; Carter, DR; Liu, B; Mayoh, C; Beckers, A; Lalwani, A; Nagy, Z; De Brouwer, S; Decaesteker, B; Hung, TT; Norris, MD; Haber, M; Liu, T; De Preter, K; Speleman, F; Cheung, BB; Marshall, GM |
| 2022-10-04 | Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. | Yuan, X; Seneviratne, JA; Du, S; Xu, Y; Chen, Y; Jin, Q; Jin, X; Balachandran, A; Huang, S; Xu, Y; Zhai, Y; Lu, L; Tang, M; Dong, Y; Cheung, BB; Marshall, GM; Shi, W; Carter, DR; Zhang, C |
| 2021-03-03 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma | Cheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM |
| 2021-07-06 | Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia | Van Thillo, Q; De Bie, J; Seneviratne, JA; Demeyer, S; Omari, S; Balachandran, A; Zhai, V; Tam, WL; Sweron, B; Geerdens, E; Gielen, O; Provost, S; Segers, H; Boeckx, N; Marshall, GM; Cheung, BB; Isobe, K; Kato, I; Takita, J; Amos, TG; Deveson, IW; McCalmont, H; Lock, RB; Oxley, EP; Garwood, MM; Dickins, RA; Uyttebroeck, A; Carter, DR; Cools, J; de Bock, CE |
| 2016-10-11 | MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. | Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE |
| 2016-08-09 | A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. | Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM |
